Subthreshold micropulse laser for adult onset Coats' associated exudative maculopathy

被引:3
作者
Kumar, Ashok [1 ]
Kumar, Poninder [1 ]
Ambiya, Vikas [2 ]
Mishra, Sanjay Kumar [3 ,4 ]
机构
[1] Armed Forces Med Coll, Pune, Maharashtra, India
[2] Command Hosp, Kolkata, India
[3] Army Coll Med Sci, New Delhi, India
[4] Base Hosp, New Delhi, India
关键词
Adult onset Coat's disease; subthreshold micropulse laser; exudative maculopathy; DISEASE;
D O I
10.1177/11206721211005691
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report subthreshold micropulse laser as novel treatment modality for exudative maculopathy associated with adult Coats' disease. Methods: A 27-year old, young male presented with exudative maculopathy in adult onset Coat's disease with profound diminution of vision. Spectral domain-optical coherence tomogram (SD-OCT) revealed macular oedema with significant subfoveal hard exudates with massive subretinal exudations temporal to macula. He was planned for anti-VEGF injection to treat macular oedema in order to preserve vision but developed conjunctivitis which made any interventional procedure impossible. Patient was managed with subthreshold micro pulse laser using 532 nm green laser. Results: Patient had significant improvement in vision, resolution of macular oedema as well as hard exudate without any adverse effects on fovea. Conclusion: Novel treatment approach in form of subthreshold micro pulse laser could be an alternative treatment modality for exudative maculopathy associated with adult onset Coat's disease, especially in cases where other available interventional treatment options are not possible.
引用
收藏
页码:NP29 / NP31
页数:3
相关论文
共 9 条
[1]   Retinal pigment epithelium produces matrix metalloproteinases after laser treatment [J].
Flaxel, Christina ;
Bradle, John ;
Acott, Ted ;
Samples, John R. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (05) :629-634
[2]   Resolution of severe macular oedema in adult Coat's syndrome with highdose intravitreal triamcinolone acetonide [J].
Jarin, RR ;
Teoh, SCB ;
Lim, TH .
EYE, 2006, 20 (02) :163-165
[3]   The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease [J].
Li, Songfeng ;
Deng, Guangda ;
Liu, Jinghua ;
Ma, Yan ;
Lu, Hai .
BMC OPHTHALMOLOGY, 2017, 17
[4]  
Ozdek Sengul C, 2011, J Pediatr Ophthalmol Strabismus, V48 Online, pe1, DOI 10.3928/01913913-20100318-05
[5]   Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction [J].
Ramasubramanian, Aparna ;
Shields, Carol L. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (03) :356-359
[6]   Coats' disease of adult-onset in 48 eyes [J].
Rishi, Ekta ;
Rishi, Pukhraj ;
Appukuttan, Bindu ;
Uparkar, Mahesh ;
Sharma, Tarun ;
Gopal, Lingam .
INDIAN JOURNAL OF OPHTHALMOLOGY, 2016, 64 (07) :518-523
[7]   Intravitreal Dexamethasone Implant (Ozurdex) in Coats' Disease [J].
Saatci, Ali Osman ;
Doruk, Hasan Can ;
Yaman, Aylin .
CASE REPORTS IN OPHTHALMOLOGY, 2013, 4 (03) :122-128
[8]   Clinical variations and complications of coats disease in 150 cases: The 2000 Stanford Gifford Memorial Lecture [J].
Shields, JA ;
Shields, CL ;
Honavar, SG ;
Demirci, H .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (05) :561-571
[9]   Classification and management of coats disease: The 2000 Proctor Lecture [J].
Shields, JA ;
Shields, CL ;
Honavar, SG ;
Demirci, H ;
Cater, J .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (05) :572-583